Table 2.
FA, g/100g | Treatment1 |
SE |
P-value |
||||
---|---|---|---|---|---|---|---|
NaHCO | NaAc | CaBu | trt | time | trt*time2 | ||
C4:0 | 4.24 | 4.21 | 4.26 | 0.065 | 0.75 | <0.001 | 0.29 |
C6:0 | 2.17 | 2.17 | 2.21 | 0.027 | 0.31 | <0.001 | 0.82 |
C8:0 | 1.18 | 1.19 | 1.20 | 0.022 | 0.37 | <0.001 | 0.34 |
C10:0 | 2.58 | 2.64 | 2.62 | 0.057 | 0.34 | <0.001 | 0.05 |
C11:0 | 0.042 | 0.042 | 0.042 | 0.002 | 0.66 | <0.001 | 0.85 |
C12:0 | 2.92 | 3.00 | 2.98 | 0.068 | 0.18 | <0.001 | 0.03 |
iso C13:0 | 0.021 | 0.020 | 0.021 | 0.001 | 0.77 | 0.68 | 0.41 |
ante-iso C13:0 | 0.056 | 0.056 | 0.059 | 0.001 | 0.16 | <0.001 | 0.02 |
iso C14:0 | 0.102 | 0.091 | 0.082 | 0.004 | <0.001 | <0.001 | 0.06 |
C14:0 | 10.1 | 10.4 | 10.1 | 0.12 | <0.01 | 0.12 | <0.001 |
iso C15:0 | 0.199 | 0.201 | 0.202 | 0.003 | 0.39 | <0.001 | 0.03 |
ante-iso C15:0 | 0.36 | 0.35 | 0.35 | 0.004 | 0.04 | 0.35 | 0.04 |
C15:0 | 0.85 | 0.83 | 0.85 | 0.012 | 0.22 | <0.001 | 0.75 |
iso C16:0 | 0.22 | 0.22 | 0.19 | 0.010 | 0.04 | <0.001 | 0.01 |
C16:0 | 25.7 | 26.6 | 25.3 | 0.13 | <0.001 | 0.01 | <0.001 |
iso C17:0 | 0.26 | 0.26 | 0.27 | 0.005 | 0.04 | <0.001 | <0.001 |
ante-iso C17:0 | 0.34 | 0.33 | 0.34 | 0.004 | 0.12 | 0.002 | 0.002 |
C17:0 | 0.46b | 0.45c | 0.47a | 0.006 | 0.001 | <0.001 | 0.22 |
C17:1 | 0.128b | 0.124b | 0.133a | 0.002 | 0.01 | 0.001 | 0.11 |
C18:0 | 12.7 | 13.0 | 12.9 | 0.17 | 0.42 | <0.01 | <0.001 |
trans−9 C18:1 | 0.33 | 0.32 | 0.34 | 0.011 | <0.001 | 0.18 | <0.001 |
trans−10 C18:1 | 0.59 | 0.59 | 0.66 | 0.020 | <0.001 | 0.04 | <0.01 |
trans−11 C18:1 | 1.27a | 1.2b | 1.27a | 0.035 | 0.01 | <0.001 | 0.25 |
cis−9 C18:1 | 19.5 | 18.8 | 19.4 | 0.56 | <0.01 | <0.001 | <0.001 |
C18:2 n-6 | 3.12 | 2.95 | 3.17 | 0.097 | <0.001 | 0.06 | <0.01 |
C18:3 n-3 | 0.47 | 0.44 | 0.47 | 0.017 | <0.01 | 0.25 | 0.01 |
cis-9,trans C18:2 | 0.54a | 0.51b | 0.53a | 0.014 | 0.01 | <0.001 | 0.12 |
Σ OBCFA3 | 3.05a | 2.96b | 3.03a | 0.026 | <0.001 | <0.001 | 0.32 |
Treatments were on a dry matter basis: 3.2% NaHCO3 (control), 2.9% NaAc, and 2.5 % CaBu (carbon equivalent to acetate treatment), n = 12 per treatment. Least-square means that do not share a superscript are significantly different (P < 0.05).
Main effects of treatment when a treatment by time interaction was detected are described in the text and shown in Supplemental Table S1.
Odd and branched chain FA.